Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH

Conversations in IFN-y explores the latest advancements in understanding and managing secondary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), with updates from ASH 2024. Featuring discussions by leading experts, the educational activity covers breakthroughs in diagnostic technologies. Topics covered include AI-based histology models and PET/CT imaging, therapeutic innovations such as emapalumab and reduced-intensity conditioning for HSCT. The implications of these findings for improving outcomes in diverse patient populations, including malignancy- and pregnancy-associated HLH will also be discussed.

Launch Date: January 9, 2025

Release Date: January 9, 2025

Expiration Date: December 31, 2025

FACULTY

Pui Lee, MD

Assistant Professor of Pediatrics

Boston Childrens Hospital

Ashish Kumar, MD, PhD

Professor of Pediatrics

Cincinnati Children's Hospital Medical Center

Alexei Grom, MD

Professor of Pediatrics

Research Director

Division of Rheumatology

Cincinnati Children’s Hospital Medical Center

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.